Protein Succination: a Mechanistic Mediator of Adipocyte Dysfunction in Diabetes
蛋白质琥珀化:糖尿病脂肪细胞功能障碍的机制介质
基本信息
- 批准号:9117530
- 负责人:
- 金额:$ 13.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAdipocytesAdipose tissueAffectAmericanAntioxidantsAttentionBiochemicalCCAAT-Enhancer-Binding ProteinsChemicalsCitric Acid CycleCysteineDataDepositionDevelopmentDiabetes MellitusEarly treatmentEndocrineEndoplasmic ReticulumEnzymesFeedbackFumarate HydrataseFumaratesFunctional disorderGlucoseHealthHomologous ProteinIn VitroInflammationInner mitochondrial membraneInsulin ResistanceKnock-outKnockout MiceLaboratoriesLeadLinkLipidsLiverMediatingMediator of activation proteinMetabolicMetabolic stressMetabolismMitochondriaMitochondrial DiseasesModelingModificationMuscleNADHNF-E2-related factor 2Non-Insulin-Dependent Diabetes MellitusNutrientOxidation-ReductionOxidative StressPathway interactionsPeripheralPost-Translational Protein ProcessingPrediabetes syndromeProtein Disulfide IsomeraseProteinsPyruvate CarboxylaseReactionRoleSelenocysteineStressSulfhydryl CompoundsTissuesUbiquitinationWorkadiponectinbasedb/db mouseebselenendoplasmic reticulum stressglucose toleranceglutathione peroxidaseinflammatory markerinnovationinsulin toleranceknock-downmouse modelnovelnovel therapeutic interventionnovel therapeuticsoverexpressionpreventprotein foldingprotein misfoldingprotein structure functionresponseselenoproteinsmall hairpin RNAtargeted treatmentthioredoxin reductase
项目摘要
DESCRIPTION (provided by applicant): Considering that ~26 million Americans have diabetes and an estimated 79 million have prediabetes, it is critical that we understand the role of expanding adipose tissue mass in the development of systemic metabolic dysfunction. However, many of the biochemical mechanisms underlying adipose tissue dysfunction remain unclear. Previously, we have detected S-(2-succinol)cysteine (2SC), also termed protein succination, a new chemical post-translational modification of proteins. 2SC is formed by reaction of the Krebs cycle intermediate fumarate with reactive cysteine residues in protein. Both fumarate and succination of proteins appear to be selectively increased in adipocytes in diabetes, impairing protein structure and function. The increase in fumarate develops as a result of excess fuel supply, accumulation of ATP and NADH, inner mitochondrial membrane (IMM) hyperpolarization and consequently feedback inhibition of the Krebs cycle. This proposal hypothesizes that the increase in protein succination is a novel mechanistic link between mitochondrial stress and the accumulation of misfolded proteins, contributing to endoplasmic reticulum (ER) stress in the adipocyte in diabetes. In addition, we propose that the succination of redox-active proteins modulates redox stress in diabetes. This project has 3 specific aims: (1) To examine the impact of fumarate accumulation and selective succination in the adipocyte; (2) To determine if succination mechanistically links mitochondrial and ER stress in the adipocyte; and (3) To examine the reactivity of fumarate with protein selenocysteines as a novel redox modulator. We plan to use a novel knockout mouse with selective fumarate accumulation in the adipose tissue. Upon completion of these studies, we will demonstrate the significant contribution of adipocyte protein succination to metabolic dysfunction in diabetes, with important implications for the development of novel therapeutic avenues for the treatment of mitochondrial diseases.
描述(由申请人提供):考虑到约2600万美国人患有糖尿病,估计有7900万人患有前驱糖尿病,我们了解脂肪组织质量扩大在全身代谢功能障碍发展中的作用至关重要。然而,许多脂肪组织功能障碍的生化机制仍不清楚。以前,我们已经检测到S-(2-琥珀酰基)半胱氨酸(2SC),也称为蛋白琥珀酸,一种新的化学蛋白质翻译后修饰。2SC是由克雷布斯循环中间体富马酸盐与蛋白质中的反应性半胱氨酸残基反应形成的。蛋白质的延胡索酸和琥珀酸化似乎在糖尿病脂肪细胞中选择性增加,损害蛋白质结构和功能。富马酸盐的增加是由于过量的燃料供应、ATP和NADH的积累、线粒体内膜(IMM)超极化以及因此对克雷布斯循环的反馈抑制。该提议假设蛋白琥珀酸化的增加是线粒体应激和错误折叠蛋白质的积累之间的一种新的机制联系,有助于糖尿病脂肪细胞中的内质网(ER)应激。此外,我们提出,琥珀酸氧化还原活性蛋白调节氧化还原应激糖尿病。该项目有3个具体目标:(1)研究脂肪细胞中富马酸积累和选择性琥珀酸化的影响;(2)确定琥珀酸化是否在脂肪细胞中机械地连接线粒体和ER应激;和(3)研究富马酸与蛋白质硒代半胱氨酸作为新型氧化还原调节剂的反应性。我们计划使用一种新的基因敲除小鼠,在脂肪组织中具有选择性富马酸盐积累。完成这些研究后,我们将证明脂肪细胞蛋白琥珀酸化对糖尿病代谢功能障碍的重要贡献,这对开发治疗线粒体疾病的新治疗途径具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Norma Frizzell其他文献
Norma Frizzell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Norma Frizzell', 18)}}的其他基金
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases
开发工具来了解尿酸盐在神经退行性疾病中的替代命运
- 批准号:
10668103 - 财政年份:2023
- 资助金额:
$ 13.35万 - 项目类别:
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy
研究复合物 I 缺陷型线粒体脑病中柠檬酸循环的扰动
- 批准号:
10609528 - 财政年份:2022
- 资助金额:
$ 13.35万 - 项目类别:
Anaplerotic Therapy for Mitochondrial Complex I Deficiency
线粒体复合物 I 缺乏症的回补疗法
- 批准号:
10118501 - 财政年份:2020
- 资助金额:
$ 13.35万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
8942973 - 财政年份:2015
- 资助金额:
$ 13.35万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
9268095 - 财政年份:2015
- 资助金额:
$ 13.35万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
9122509 - 财政年份:2015
- 资助金额:
$ 13.35万 - 项目类别:
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease
检测 S-(2-琥珀酰)半胱氨酸 (2SC) 作为线粒体疾病的生物标志物
- 批准号:
8571892 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease
检测 S-(2-琥珀酰)半胱氨酸 (2SC) 作为线粒体疾病的生物标志物
- 批准号:
8725715 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Recruitment of brown adipocytes in visceral white adipose tissue by fibroblast growth factor 8b
成纤维细胞生长因子 8b 将棕色脂肪细胞募集到内脏白色脂肪组织中
- 批准号:
321208980 - 财政年份:2016
- 资助金额:
$ 13.35万 - 项目类别:
Research Grants
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8827438 - 财政年份:2014
- 资助金额:
$ 13.35万 - 项目类别:
Induction of brown-like adipocytes in white adipose tissue by food-derived factors
食物源性因子在白色脂肪组织中诱导棕色样脂肪细胞
- 批准号:
26450168 - 财政年份:2014
- 资助金额:
$ 13.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
WAT-on-a-chip - Development of a micofluidic, microphysiologic in vitro adipose tissue model for high-throughput drug screening based on hiPSC-derived adipocytes.
WAT-on-a-chip - 开发微流体、微生理体外脂肪组织模型,用于基于 hiPSC 衍生脂肪细胞的高通量药物筛选。
- 批准号:
257256526 - 财政年份:2014
- 资助金额:
$ 13.35万 - 项目类别:
Research Fellowships
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8828181 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8520690 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8629741 - 财政年份:2013
- 资助金额:
$ 13.35万 - 项目类别:
Effect of exercise training on formation of brite adipocytes within white adipose tissue
运动训练对白色脂肪组织内脂肪细胞形成的影响
- 批准号:
23700778 - 财政年份:2011
- 资助金额:
$ 13.35万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Investigation for the mechanisms of the emergence of brown adipocytes in white adipose tissue
白色脂肪组织中棕色脂肪细胞出现机制的研究
- 批准号:
21780261 - 财政年份:2009
- 资助金额:
$ 13.35万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
LOUISIANA COBRE: P1: INDUCE THERMOGENIC BROWN ADIPOCYTES IN WHITE ADIPOSE TISSUE
路易斯安那 COBRE:P1:在白色脂肪组织中诱导产热棕色脂肪细胞
- 批准号:
7610781 - 财政年份:2007
- 资助金额:
$ 13.35万 - 项目类别: